• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在人体中使用冠状窦的有效且适应性强的经静脉除颤系统。

An effective and adaptable transvenous defibrillation system using the coronary sinus in humans.

作者信息

Bardy G H, Allen M D, Mehra R, Johnson G

机构信息

Department of Medicine, University of Washington, Seattle.

出版信息

J Am Coll Cardiol. 1990 Oct;16(4):887-95. doi: 10.1016/s0735-1097(10)80337-7.

DOI:10.1016/s0735-1097(10)80337-7
PMID:2212369
Abstract

With use of a coronary sinus catheter electrode, a right ventricular catheter electrode and a chest wall patch electrode system, defibrillation threshold voltage, current and energy were measured with four distinct transvenous defibrillation techniques delivered in random sequence in each of 12 survivors of cardiac arrest immediately before implantation of a standard epicardial patch defibrillation system. The four transvenous defibrillation techniques were 1) single pathway monophasic pulsing, 2) single pathway biphasic pulsing, 3) dual pathway sequential pulsing, and 4) dual pathway simultaneous pulsing. A transvenous defibrillation method was considered to be potentially useful only if the defibrillation threshold was less than or equal to 500 V (less than or equal to 15 J delivered energy). The 500 V value would allow a 2:1 defibrillation safety margin for a device with a maximal output of 30 J. No single transvenous pulsing technique was uniformly superior in efficacy. However, by choosing the best pulsing technique for each patient, it was possible to obtain an average defibrillation threshold of 410 +/- 135 V leading edge voltage, 7.2 +/- 2.5 A leading edge current and 11.3 +/- 7.4 J delivered energy for the group of 12 patients. With the ability to vary defibrillation technique, transvenous antiarrhythmic device implantation would have been possible in 10 (83%) of the 12 patients at or below a 15 J defibrillation threshold cutoff point. In contrast, if only one transvenous defibrillation method had been used, as few as 5 and at most 8 of the 12 patients would have been candidates for a transvenous defibrillation system given a 15 J defibrillation threshold cutoff point for insertion.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在12名心脏骤停幸存者植入标准心外膜贴片除颤系统之前,使用冠状窦导管电极、右心室导管电极和胸壁贴片电极系统,以随机顺序采用四种不同的经静脉除颤技术测量除颤阈值电压、电流和能量。这四种经静脉除颤技术分别为:1)单路径单相脉冲;2)单路径双相脉冲;3)双路径顺序脉冲;4)双路径同步脉冲。仅当除颤阈值小于或等于500V(输送能量小于或等于15J)时,经静脉除颤方法才被认为可能有用。500V的值将为最大输出为30J的设备提供2:1的除颤安全裕度。没有一种经静脉脉冲技术在疗效上始终具有优势。然而,通过为每位患者选择最佳脉冲技术,12名患者组的平均除颤阈值可达到前沿电压410±135V、前沿电流7.2±2.5A和输送能量11.3±7.4J。由于能够改变除颤技术,12名患者中有10名(83%)在15J除颤阈值截止点或以下时有可能植入经静脉抗心律失常装置。相比之下,如果仅使用一种经静脉除颤方法,对于15J除颤阈值截止点的植入而言,12名患者中只有5至8名可能成为经静脉除颤系统的候选者。(摘要截断于250字)

相似文献

1
An effective and adaptable transvenous defibrillation system using the coronary sinus in humans.一种在人体中使用冠状窦的有效且适应性强的经静脉除颤系统。
J Am Coll Cardiol. 1990 Oct;16(4):887-95. doi: 10.1016/s0735-1097(10)80337-7.
2
Transvenous defibrillation in humans via the coronary sinus.
Circulation. 1990 Apr;81(4):1252-9. doi: 10.1161/01.cir.81.4.1252.
3
Combination biphasic waveform plus sequential pulse defibrillation improves defibrillation efficacy of a nonthoracotomy lead system.双相波形联合顺序脉冲除颤可提高非开胸导联系统的除颤效果。
J Am Coll Cardiol. 1994 Feb;23(2):317-22. doi: 10.1016/0735-1097(94)90413-8.
4
Biphasic waveform defibrillation using a three-electrode transvenous lead system in humans.在人体中使用三电极经静脉导联系统进行双相波形除颤。
J Cardiovasc Electrophysiol. 1994 Feb;5(2):103-8. doi: 10.1111/j.1540-8167.1994.tb01149.x.
5
Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systems.
J Am Coll Cardiol. 1989 Jul;14(1):165-71. doi: 10.1016/0735-1097(89)90068-5.
6
Electrode system influence on biphasic waveform defibrillation efficacy in humans.电极系统对人体双相波形除颤疗效的影响。
Circulation. 1991 Aug;84(2):665-71. doi: 10.1161/01.cir.84.2.665.
7
Implantable transvenous cardioverter-defibrillators.植入式经静脉心脏复律除颤器
Circulation. 1993 Apr;87(4):1152-68. doi: 10.1161/01.cir.87.4.1152.
8
Intraoperative comparison of sequential-pulse and single-pulse defibrillation in candidates for automatic implantable defibrillators.
Am J Cardiol. 1987 Sep 1;60(7):618-24. doi: 10.1016/0002-9149(87)90316-x.
9
Efficacy of a single-lead unipolar transvenous defibrillator compared with a system employing an additional coronary sinus electrode. A prospective, randomized study.单极经静脉除颤器与采用附加冠状窦电极系统的疗效比较。一项前瞻性随机研究。
Circulation. 1994 Jun;89(6):2641-4. doi: 10.1161/01.cir.89.6.2641.
10
Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode.在人体中对单极除颤系统与使用额外上腔静脉电极的除颤系统进行前瞻性随机比较。
Circulation. 1994 Mar;89(3):1090-3. doi: 10.1161/01.cir.89.3.1090.

引用本文的文献

1
Experience with unipolar pectoral defibrillation.单极胸壁除颤的经验。
Herzschrittmacherther Elektrophysiol. 1997 Mar;8(1):32-8. doi: 10.1007/BF03042475.
2
A systematic evaluation of conventional and novel transvenous pathways for defibrillation.
J Interv Card Electrophysiol. 1999 Oct;3(3):231-8. doi: 10.1023/a:1009895623802.
3
The middle cardiac vein--a novel pathway to reduce the defibrillation threshold.
J Interv Card Electrophysiol. 1999 Mar;3(1):55-60. doi: 10.1023/a:1009827607495.
4
A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes.
J Interv Card Electrophysiol. 1998 Dec;2(4):345-9. doi: 10.1023/a:1009756520054.
5
Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks.经胸电击难治性心房颤动的低能量体内复律
Heart. 1996 Jun;75(6):635-8. doi: 10.1136/hrt.75.6.635.